CDD-1819

• UNSPSC Description:

  CDD-1819 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 5 nM. CDD-1819 also inhibits ΔP168, A173V, and ΔP168/A173V Mpro variants[1].

• Target Antigen:

  SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/cdd-1819.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(NC)[C@@](C1)([H])C[C@]1([H])N2C(C3=C(C=CC=C4)C4=CN=C3)=NC5=C2C(C(N[C@@H](C)C6=CC=C(C=CC=C7)C7=C6)=O)=CC=C5

• Molecular Weight:

  553.65

• References & Citations:

  [1]Ravikumar Jimmidi, et al. DNA-encoded chemical libraries yield non-covalent and non-peptidic SARS-CoV-2 main protease inhibitors. Commun Chem. 2023 Aug 4;6(1):164.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2894104-40-4